- Datum11.09.2024
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen![stock3 Terminal Chart](/img/banner/chart-light.png)
Cosmo Pharmaceuticals N.V. Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Tradegate | VK | |||||
Stuttgart | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (SIX)
Wikifolio
Passender Service zu Cosmo Pharmaceuticals N.V.
Webinar zu Cosmo Pharmaceuticals N.V.
Kursinformationen (SIX)
- Tagestief / Hoch (Fr)-
- 52W-Tief / Hoch (Fr)33,700-80,600
- Jahrestief / Hoch (Fr)51,200-80,600
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Cosmo Pharmaceuticals N.V.
Termine von Cosmo Pharmaceuticals N.V.
- Mär19Cosmo Pharmaceuticals N.V.Q4 2024 Earnings Release
- Jul24Cosmo Pharmaceuticals N.V.Q2 2025 Earnings Release
- Mär19Cosmo Pharmaceuticals N.V.Q4 2025 Earnings Release
Beschreibung
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.